FI89168C - Foerfarande foer framstaellning av farmaceutiskt aktiva n-piperidylbenzamider - Google Patents

Foerfarande foer framstaellning av farmaceutiskt aktiva n-piperidylbenzamider Download PDF

Info

Publication number
FI89168C
FI89168C FI863179A FI863179A FI89168C FI 89168 C FI89168 C FI 89168C FI 863179 A FI863179 A FI 863179A FI 863179 A FI863179 A FI 863179A FI 89168 C FI89168 C FI 89168C
Authority
FI
Finland
Prior art keywords
compound
group
formula
amino
piperid
Prior art date
Application number
FI863179A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI863179A0 (fi
FI89168B (fi
FI863179A (fi
Inventor
Noverola Armando Vega
Soto Jose Manuel Prieto
Noguera Fernando Pujol
Mauri Jacinto Moragues
Robert Geoffrey Willi Spickett
Original Assignee
Walton Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walton Sa filed Critical Walton Sa
Publication of FI863179A0 publication Critical patent/FI863179A0/fi
Publication of FI863179A publication Critical patent/FI863179A/fi
Publication of FI89168B publication Critical patent/FI89168B/fi
Application granted granted Critical
Publication of FI89168C publication Critical patent/FI89168C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/66—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having a hetero atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI863179A 1985-08-06 1986-08-04 Foerfarande foer framstaellning av farmaceutiskt aktiva n-piperidylbenzamider FI89168C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858519707A GB8519707D0 (en) 1985-08-06 1985-08-06 Chemical compounds
GB8519707 1985-08-06

Publications (4)

Publication Number Publication Date
FI863179A0 FI863179A0 (fi) 1986-08-04
FI863179A FI863179A (fi) 1987-02-07
FI89168B FI89168B (fi) 1993-05-14
FI89168C true FI89168C (fi) 1993-08-25

Family

ID=10583372

Family Applications (1)

Application Number Title Priority Date Filing Date
FI863179A FI89168C (fi) 1985-08-06 1986-08-04 Foerfarande foer framstaellning av farmaceutiskt aktiva n-piperidylbenzamider

Country Status (28)

Country Link
US (1) US4772618A (ko)
EP (1) EP0213775B1 (ko)
JP (1) JPH0662614B2 (ko)
KR (1) KR920001763B1 (ko)
CN (1) CN1022830C (ko)
AR (2) AR243521A1 (ko)
AT (1) ATE49206T1 (ko)
AU (1) AU596110B2 (ko)
CA (1) CA1300154C (ko)
DD (1) DD287502A5 (ko)
DE (1) DE3667975D1 (ko)
DK (1) DK370586A (ko)
EG (1) EG18154A (ko)
ES (2) ES2000706A6 (ko)
FI (1) FI89168C (ko)
GB (1) GB8519707D0 (ko)
GR (1) GR862060B (ko)
HU (1) HU201060B (ko)
IE (1) IE58751B1 (ko)
IL (1) IL79469A0 (ko)
MX (1) MX3375A (ko)
MY (1) MY101352A (ko)
NO (1) NO168706C (ko)
NZ (1) NZ217078A (ko)
PH (1) PH25019A (ko)
PL (1) PL150228B1 (ko)
PT (2) PT83146B (ko)
ZA (1) ZA865537B (ko)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2640139A1 (fr) * 1988-12-14 1990-06-15 Delagrange Laboratoires Application de benzamides substitues comme gastromoteurs
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
JP2999669B2 (ja) * 1993-08-24 2000-01-17 株式会社三和化学研究所 ベンゾ［ｂ］フランカルボキサミド誘導体、その製法及び用途
JPH0820586A (ja) * 1994-07-05 1996-01-23 Sanwa Kagaku Kenkyusho Co Ltd １−アザビシクロ［３．３．０］オクタン誘導体、その塩及び製法並びに用途
JPH0873463A (ja) 1994-07-05 1996-03-19 Sanwa Kagaku Kenkyusho Co Ltd ベンゾピランカルボキサミド誘導体、その塩及び製法並びに用途
CN1052228C (zh) * 1996-01-17 2000-05-10 中国科学院大连化学物理研究所 N-甲酰基哌啶及其同系物的制备方法
CN1091104C (zh) * 1998-04-02 2002-09-18 中国科学院大连化学物理研究所 一种n－甲酰基哌啶的制备方法
CN1649766A (zh) 2002-06-11 2005-08-03 安芸电器株式会社 自行车的前照灯以及前照灯电路
DK2194053T3 (da) * 2004-01-07 2013-07-01 Armetheon Inc Methoxypiperidinderivater til brug i behandling af gastrointestinale forstyrrelser og forstyrrelser i centralnervesystemet.
GB0525661D0 (en) * 2005-12-16 2006-01-25 Glaxo Group Ltd Novel compounds
MX2013002409A (es) * 2010-09-01 2013-04-03 Janssen Pharmaceutica Nv Antagonistas del receptor 5-ht2b.
CN110950843B (zh) * 2019-11-28 2022-12-27 广东东阳光药业有限公司 取代的苯酰胺衍生物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1019781A (ko) 1963-03-05
US3342826A (en) 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
GB1507462A (en) * 1974-03-21 1978-04-12 Gallardo Antonio Sa N-heterocyclic substituted benzamides methods for their preparation and compositions containing them
GB1574418A (en) * 1976-11-16 1980-09-03 Anphar Sa Piperidine derivatives
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives

Also Published As

Publication number Publication date
PT83147A (en) 1986-09-01
GR862060B (en) 1986-12-24
NO168706B (no) 1991-12-16
EP0213775B1 (en) 1990-01-03
MX3375A (es) 1993-12-01
FI863179A0 (fi) 1986-08-04
IL79469A0 (en) 1986-10-31
CN1022830C (zh) 1993-11-24
AU6075886A (en) 1987-02-12
AR242793A1 (es) 1993-05-31
FI89168B (fi) 1993-05-14
IE58751B1 (en) 1993-11-03
EP0213775A1 (en) 1987-03-11
KR870002071A (ko) 1987-03-28
PL260921A1 (en) 1988-01-07
NZ217078A (en) 1989-01-27
US4772618A (en) 1988-09-20
CA1300154C (en) 1992-05-05
FI863179A (fi) 1987-02-07
MY101352A (en) 1991-09-05
PH25019A (en) 1991-01-28
NO863139D0 (no) 1986-08-04
ES2000705A6 (es) 1988-03-16
PT83147B (pt) 1988-07-29
NO168706C (no) 1992-03-25
PT83146A (en) 1986-09-01
DK370586D0 (da) 1986-08-04
NO863139L (no) 1987-02-09
ES2000706A6 (es) 1988-03-16
KR920001763B1 (ko) 1992-03-02
DD287502A5 (de) 1991-02-28
JPS62129279A (ja) 1987-06-11
DK370586A (da) 1987-03-27
HU201060B (en) 1990-09-28
HUT44782A (en) 1988-04-28
ZA865537B (en) 1987-03-25
GB8519707D0 (en) 1985-09-11
PL150228B1 (en) 1990-05-31
JPH0662614B2 (ja) 1994-08-17
AU596110B2 (en) 1990-04-26
AR243521A1 (es) 1993-08-31
ATE49206T1 (de) 1990-01-15
IE862073L (en) 1987-02-06
CN86105972A (zh) 1987-04-01
DE3667975D1 (en) 1990-02-08
PT83146B (pt) 1988-07-29
EG18154A (en) 1992-11-30

Similar Documents

Publication Publication Date Title
SU1739849A3 (ru) Способ получени производных бензамида или их фармакологически приемлемых солей
FI89168C (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva n-piperidylbenzamider
AU685225B2 (en) Novel carbamate derivative and medicinal composition containing the same
DE69403823T2 (de) Substituierte Phenylsulfonamine als selektive B3-Agonisten zur Behandlung von Diabetes und Fettleibigkeit
DE69922494T2 (de) Zyklische n-acylamin-derivate
US5864039A (en) Benzoic acid compounds and use thereof as medicaments
JPH04208267A (ja) 新規な複素環式化合物およびそれを含有する医薬組成物
JPH10511973A (ja) タキキニンアンタゴニスト活性を有するピペリジン誘導体
CA2623359A1 (en) 9-azabicyclo [3.3.1] nonane derivatives as monoamine reuptake inhibitors
DE69429147T2 (de) Benzamidderivate
US5391549A (en) Cinnoline-3-carboxylic acid derivatives
AU2014225550B2 (en) Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
HU189599B (en) Process for producing amidobenzamide derivatives and pharmaceutical compositions containing them
HU208538B (en) Process for producing dihydro-benzofurane-carboxamide derivatives and pharmaceutical compositions containing them as active components
BRPI0618971A2 (pt) compostos derivados de isoqionolina e benzo [h] isoqionolina, composição farmacêutica, utilização dos compostos e processo de preparo dos compostos
SK9398A3 (en) (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2- -methoxy-6-methylamino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same
JPH06503331A (ja) 医薬品
MXPA06002780A (es) Inhibidores de entrada del virus de vih.
DE60000500T2 (de) Substituierte n-(piperidin-4-yl)-4h-3,1-benzo(thia/oxa)zin-2-amine, ihre herstellung und therapeutische verwendung
US4868315A (en) Novel aryloxycycloalkanolaminoalkylene aryl ketones
EP0785195A1 (en) Piperidine or tetrahydropyridine derivatives having affinity for the serotonin 5-HTIA receptor
JPH07500590A (ja) ５−ｈｔ３アンタゴニストとして有用なピリジン−３−カルボン酸エステルまたはアミド
RU2043991C1 (ru) Дигидробензофурановые карбоксамиды или его фармацевтически приемлемые соли и способ их получения
JPS6341395B2 (ko)
JP2008535828A (ja) ピペラジニル置換シクロヘキサン１，４−ジアミン

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: WALTON S.A.